Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:9
作者
Kyritsi, Eleni-Magdalini [1 ]
Koltsida, Georgia [1 ]
Farakla, Ioanna [1 ]
Papanikolaou, Aikaterini [2 ]
Critselis, Elena [1 ]
Mantzou, Emilia [1 ]
Zoumakis, Emmanouil [1 ]
Kolaitis, Gerasimos [2 ]
Chrousos, George P. [1 ,3 ]
Charmandari, Evangelia [1 ,3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet,Dept Pediat 1, Thivon & Papadiamantopoulou St, Athens 11527, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Dept Child Psychiat, Athens, Greece
[3] Acad Athens, Div Endocrinol & Metab, Biomed Res Fdn, Clin Res Ctr, Athens, Greece
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2017年 / 16卷 / 01期
关键词
Anxiety; Carriers; Congenital adrenal hyperplasia; Depression; 21-hydroxylase deficiency; HORMONE-RECEPTOR ANTAGONIST; HPA AXIS; SALIVARY CORTISOL; DEPRESSION; ANXIETY; SYSTEM; DISORDERS; CRH; NEUROENDOCRINE; INVENTORY;
D O I
10.14310/horm.2002.1718
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Carriers of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) demonstrate increased secretion of cortisol precursors following ACTH stimulation, suggestive of impaired cortisol production and compensatory increases in hypothalamic corticotropin-releasing hormone (CRH) secretion. Both cortisol and CRH have behavioral effects, and hypothalamic CRH hypersecretion has been associated with chronic states of anxiety and depression. We performed an endocrinologic and psychological evaluation in carriers of 21-OHD and matched control subjects. DESIGN: We recruited 29 parents of children with classic CAH (14 males, 15 females; age (mean +/- SD): 41.8 +/- 5.7 yr), and hence 21-OHD carriers, and 13 normal subjects (5 males, 8 females; age: 43.8 +/- 6.1 yr). All subjects underwent a formal ovine (o) CRH stimulation test with measurement of ACTH, cortisol, 17-hydroxyprogesterone (17-OHP) and androstenedione concentrations, which was preceded by determination of 24-hour urinary free cortisol (UFC) excretion. Psychometric assessment was performed by administering the State-Anxiety (STAI 1) and Trait-Anxiety (STAI 2) Inventory, Beck Depression Inventory, Symptom Checklist-90R and Temperament and Character Inventory. RESULTS : Carriers of 21-OHD had significantly higher 17-OHP concentrations following oCRH stimulation and higher STAI 1 (47.6 +/- 5.6 vs. 43.3 +/- 5.4, P=0.023) scores than control subjects. Mean 24-hour UFC concentrations were positively correlated with paranoid ideation (r=0.435; P=0.023) and psychoticism (r=0.454; P=0.017). Stepwise multiple linear regression analysis revealed that the single independent predictor of STAI 1 was peak stimulated 17-OHP concentrations (beta: 0.055, SE: 0.023, R-2: 0.290, P=0.031). CONCLUSIONS : Carriers of 21-OHD may be predisposed to the development of anxiety disorders.
引用
收藏
页码:42 / 53
页数:12
相关论文
共 39 条
[1]   Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm [J].
Ayala, AR ;
Pushkas, J ;
Higley, JD ;
Ronsaville, D ;
Gold, PW ;
Chrousos, GP ;
Pacak, K ;
Calis, KA ;
Gerald, M ;
Lindell, S ;
Rice, KC ;
Cizza, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) :5729-5737
[2]   The stress system in depression and neurodegeneration: Focus on the human hypothalamus [J].
Bao, A. -M. ;
Meynen, G. ;
Swaab, D. F. .
BRAIN RESEARCH REVIEWS, 2008, 57 (02) :531-553
[3]   Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population [J].
Baumgartner-Parzer, SM ;
Nowotny, P ;
Heinze, G ;
Waldhäusl, W ;
Vierhapper, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :775-778
[4]  
Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151
[5]   Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: Evidence for physical and/or psychologic vulnerability to stress [J].
Charmandari, E ;
Merke, DP ;
Negro, PJ ;
Keil, MF ;
Martinez, PE ;
Haim, A ;
Gold, PW ;
Chrousos, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2228-2236
[6]   Pediatric stress: Hormonal mediators and human development [J].
Charmandari, E ;
Kino, T ;
Souvatzoglou, E ;
Chrousos, GP .
HORMONE RESEARCH, 2003, 59 (04) :161-179
[7]   Endocrinology of the stress response [J].
Charmandari, E ;
Tsigos, C ;
Chrousos, G .
ANNUAL REVIEW OF PHYSIOLOGY, 2005, 67 :259-284
[8]   Stress and disorders of the stress system [J].
Chrousos, George P. .
NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (07) :374-381
[9]   SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND IMMUNE-MEDIATED INFLAMMATION [J].
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1351-1362
[10]   THE TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE - UNITED-STATES NORMATIVE DATA [J].
CLONINGER, CR ;
PRZYBECK, TR ;
SVRAKIC, DM .
PSYCHOLOGICAL REPORTS, 1991, 69 (03) :1047-1057